Publications by authors named "Emi Holmes"

Claim this Profile
P
Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group.
Bruce H Cohen, J Russell Geyer, Douglas C Miller, John G Curran, Tianni Zhou, Emi Holmes

Pediatr Neurol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group.
Vandana Batra, Stephen A Sands, Emi Holmes, Jeffrey Russell Geyer, Allan Yates

Pediatr Blood Cancer· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intellectual and academic outcome following two chemotherapy regimens and radiotherapy for average-risk medulloblastoma: COG A9961.
M Douglas Ris, Karin Walsh, Dana Wallace, F Daniel Armstrong, Emi Holmes

Pediatr Blood Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.
Roger J Packer, Tianni Zhou, Emi Holmes, Gilbert Vezina, Amar Gajjar

Neuro Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinoma.
Jeffrey Allen, Jeena Chacko, Bernadine Donahue, Girish Dhall, Cynthia Kretschmar, Emi Holmes

Pediatr Blood Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group.
James H Garvin, Michael T Selch, Emi Holmes, Mitchell S Berger, Jonathan L Finlay

Pediatr Blood Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
Jeffrey Allen, Bernadine Donahue, Minesh Mehta, Douglas C Miller, Lucy B Rorke, Emi Holmes

Int J Radiat Oncol Biol Phys· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.
Richard P Kadota, Donald H Mahoney, John Doyle, Reggie Duerst, Henry Friedman, Emi Holmes

Pediatr Blood Cancer· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive and adaptive outcome in extracerebellar low-grade brain tumors in children: a report from the Children's Oncology Group.
M Douglas Ris, Dean W Beebe, F Daniel Armstrong, John Fontanesi, Emi Holmes

J Clin Oncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors.
Tarik Tihan, Tianni Zhou, Emi Holmes, Peter C Burger, Sema Ozuysal

Mod Pathol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study.
Maryam Fouladi, H Stacy Nicholson, Tianni Zhou, Fred Laningham, Kathleen J Helton, Emi Holmes

Cancer· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: a report from the Children's Oncology Group.
C Kretschmar, L Kleinberg, M Greenberg, P Burger, Emi Holmes

Pediatr Blood Cancer· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.
Murali M Chintagumpala, Henry S Friedman, Clinton F Stewart, James Kepner, Roger E McLendon, Emi Holmes

J Neurooncol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
Tobey J MacDonald, Edward B Arenson, Joann Ater, Richard Sposto, Herbert E Bevan, Emi Holmes

Cancer· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies (CCG 9891/POG 9130).
Dean W Beebe, M Douglas Ris, F Daniel Armstrong, John Fontanesi, Raymond Mulhern, Emi Holmes

J Clin Oncol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Edward Pan, Malgorzata Pellarin, Emi Holmes, Ivan Smirnov, Anjan Misra

Clin Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.
Mark T Jennings, Richard Sposto, James M Boyett, L Gilbert Vezina, Emi Holmes

J Clin Oncol· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis